At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- PositionGross margin is 32.2%, lower than 95% of its Medical Devices peers (median 64.2%)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.99BCNY447.41M · vs all stocks (USD)
Revenue (TTM)
319.79MCNY47.91M · vs all stocks (USD)
Profit Margin
-9.27%vs Medical Devices peers
Beta
0.3910xvs all stocks
52-Week Change
24.14%vs all stocks
Market Capitalization
2.99BCNY447.41M · vs all stocks (USD)
Enterprise Value
2.94BCNY440.96M · vs all stocks (USD)
Forward P/E
54.90xvs Medical Devices peers
Price to Sales (TTM)
8.78xvs Medical Devices peers
Price to Book (MRQ)
3.32xvs Medical Devices peers
Enterprise to Revenue
9.21xvs Medical Devices peers
Enterprise to EBITDA
-162.42xvs Medical Devices peers
Gross Margin
32.24%vs Medical Devices peers
Profit Margin
-9.27%vs Medical Devices peers
Operating Margin
-16.75%vs Medical Devices peers
Return on Assets (TTM)
-1.36%vs Medical Devices peers
Return on Equity (TTM)
-3.70%vs Medical Devices peers
Revenue (TTM)
319.79MCNY47.91M · vs all stocks (USD)
Revenue per Share (TTM)
3.54CNYUpdated Oct 24, 2026Quarterly Revenue Growth
-12.90%vs Medical Devices peers
Gross Profit (TTM)
101.40MCNY15.19M · vs all stocks (USD)
EBITDA (TTM)
21.30MCNY3.19M · vs all stocks (USD)
Net Income (TTM)
-29.64MCNY-4.44M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
28.82%vs Medical Devices peers
Operating Cash Flow (TTM)
-40.74MCNY-6.10M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
24.07MCNY3.61M · vs all stocks (USD)
5-Year Average Dividend Yield
0.33%vs all stocks
Payout Ratio
101.67%vs Medical Devices peers
Minority Interest (Equity)
-803.12KCNYFY2025 · Dec 31, 2025Revenue
320.86MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
203.30MCNYFY2025 · Dec 31, 2025Gross Profit
117.56MCNYFY2025 · Dec 31, 2025Operating Income
19.99MCNY2.99M · vs all stocks (USD)
Pre-tax Income
-9.48MCNYFY2025 · Dec 31, 2025Income Tax Expense
-2.16MCNYFY2025 · Dec 31, 2025Net Income
-7.33MCNYFY2025 · Dec 31, 2025EBIT
-8.53MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
21.30MCNYFY2025 · Dec 31, 2025Research & Development
32.05MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
20.38MCNYFY2025 · Dec 31, 2025Other Operating Expenses
1.14MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
675.78KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
950.25KCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0800CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0800CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
83.34MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
83.34MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-7.33MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
662.13KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-113.21MCNYFY2025 · Dec 31, 2025Free Cash Flow
-178.88MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
212.02MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-7.33MCNYFY2025 · Dec 31, 2025Other Non-cash Items
5.72MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-32.04MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-79.56MCNYFY2025 · Dec 31, 2025Capital Expenditures
-65.67MCNYFY2025 · Dec 31, 2025Purchase of Investments
-38.00MCNYFY2025 · Dec 31, 2025Sale of Investments
4.55MCNYFY2025 · Dec 31, 2025Other Investing Activity
144.36MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
45.23MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
67.34MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-37.59MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-5.95MCNYFY2025 · Dec 31, 2025Other Financing Charges
-4.29MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
19.50MCNYFY2025 · Dec 31, 2025Shares Outstanding
88.13MSharesUpdated Oct 24, 2026Float Shares
59.43MSharesUpdated Oct 24, 2026% Held by Insiders
35.38%vs all stocks
% Held by Institutions
6.39%vs all stocks
Total Cash (MRQ)
269.78MCNY40.41M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.09CNYUpdated Oct 24, 2026Total Debt (MRQ)
366.13MCNY54.85M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4063xvs Medical Devices peers
Current Ratio (MRQ)
1.92xvs Medical Devices peers
Book Value per Share (MRQ)
9.59CNYUpdated Oct 24, 2026Total Assets
977.93MCNY146.49M · vs all stocks (USD)
Total Current Assets
532.17MCNYFY2025 · Dec 31, 2025Total Liabilities
124.52MCNYFY2025 · Dec 31, 2025Total Non-current Assets
445.75MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
13.08MCNYFY2025 · Dec 31, 2025Total Current Liabilities
111.44MCNYFY2025 · Dec 31, 2025Cash
212.02MCNYFY2025 · Dec 31, 2025Cash Equivalents
1.39MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
213.41MCNYFY2025 · Dec 31, 2025Other Short-term Investments
30.04MCNYFY2025 · Dec 31, 2025Accounts Receivable
111.55MCNYFY2025 · Dec 31, 2025Inventory
151.75MCNYFY2025 · Dec 31, 2025Accounts Payable
57.17MCNYFY2025 · Dec 31, 2025Short-term Debt
35.71MCNYFY2025 · Dec 31, 2025Other Current Liabilities
542.76KCNYFY2025 · Dec 31, 2025Long-term Debt
6.77MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
2.02MCNYFY2025 · Dec 31, 2025Common Stock (Book)
88.13MCNYFY2025 · Dec 31, 2025Retained Earnings
189.54MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
853.41MCNY127.84M · vs all stocks (USD)
Treasury Stock
10.00MCNYFY2025 · Dec 31, 202552-Week Low
26.85CNYUpdated Oct 24, 202652-Week High
73.00CNYUpdated Oct 24, 202652-Week Change
24.14%vs all stocks
Beta
0.3910xvs all stocks
50-Day MA
38.54CNYUpdated Oct 24, 2026200-Day MA
51.06CNYUpdated Oct 24, 2026Avg 10-Day Volume
1.43MSharesUpdated Oct 24, 2026Avg 30-Day Volume
1.21MSharesUpdated Oct 24, 2026Diluted EPS (TTM)
-0.3400CNYUpdated Oct 24, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 32.2%, lower than 95% of its Medical Devices peers (median 64.2%)Significant
Gross margin: 0.32Industry median: 0.64Industry P5: 0.34Peers compared: 105
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
NeuroPace Inc.
Tier 1ProductionApproval-Gated PipelineRule
Guanhao Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Pku Healthcare Corporation Limited
Tier 1ProductionApproval-Gated PipelineRule
Guangdong Transtek Medical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tellgen Corporation
Tier 1ProductionApproval-Gated PipelineRule
Gujarat Themis Biosyn Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Clover Biopharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Prothena Corporation plc
Tier 1ProductionApproval-Gated PipelineRuleRisk
Anhui Sunhere Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Eupraxia Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk